The European Patent Office (EPO) has issued a patent grant, EP2699693B1, for methods concerning the isolation of a target analyte from heterogeneous samples. This grant includes specific International Patent Classifications (IPC) such as C12Q 1/6806, G01N 33/543, C07K 16/12, C07K 1/22, and C12N 13/00, indicating its relevance to molecular diagnostics, immunoassays, and protein isolation techniques.

This patent grant signifies the EPO's recognition of novel methods in biotechnology and analytical chemistry. While not a regulatory rule imposing obligations, it establishes intellectual property rights for the named inventors and their assignees. Companies operating in the biotech and pharmaceutical sectors, particularly those involved in diagnostic assay development or sample preparation, should be aware of this patent as it may affect their freedom to operate or potential licensing requirements.